Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intracavernosal Exosomes Versus Rectal Ozone Therapy for Erectile Dysfunction Following Robotic-Assisted Radical Prostatectomy

NCT07707505 is registered in ClinicalTrials.gov with Medipol University as lead sponsor.

NCT NCT07707505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07707505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intracavernosal Exosomes Versus Rectal Ozone Therapy for Erectile Dysfunction Following Robotic-Assisted Radical Prostatectomy
Lead sponsor
Medipol University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
April 1, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erectile dysfunction following radical prostatectomy